← brief for 2026-08-21 · Slowing decline

Baxdrostat: First Approval.

Key takeaways

A new blood pressure drug called baxdrostat won its first approval in the United States on May 15, 2026. It blocks aldosterone, a hormone that raises blood pressure and can harm the kidneys. It is approved for high blood pressure and is being studied for kidney disease too. This is an approval announcement, so no new trial results are reported here.

Who did this work

Blair HA

Source

Article · PubMed, CKD progression and prevention · 2026 Aug 21
https://pubmed.ncbi.nlm.nih.gov/42625106/